Bone health · Dental care and medication safety
Osteoporosis Medicines and Dental Work: What to Tell Your Dentist Before an Extraction
Jaw complications linked to some bone medicines are uncommon at osteoporosis doses, but dental teams should know what you take. Here is what current guidance says about routine care, extractions, and medication changes.
Keep dental care and fracture prevention in the same conversation
A planned tooth extraction can prompt a difficult question: should someone taking osteoporosis medicine delay dental treatment or pause the medicine? The short answer is that there is no one-size-fits-all answer, and a patient should not make that decision alone. Medication-related osteonecrosis of the jaw (MRONJ) is an uncommon but recognized complication associated with certain bone medicines. At the same time, untreated dental infection and fragility fractures can both cause serious harm. The safest approach is coordinated planning between the dentist and the clinician who prescribed the osteoporosis medicine, with the specific procedure and treatment history considered.
Which osteoporosis medicines are relevant?
Some medicines used to reduce fracture risk slow bone breakdown. These include bisphosphonates such as alendronate or zoledronic acid and denosumab, a RANKL inhibitor. Routes and schedules differ: some bisphosphonates are taken by mouth, some are given by infusion, and denosumab is given by injection on a set schedule. Not every osteoporosis medicine belongs to the same class, and medicines given at high doses for cancer-related bone disease are a different clinical context. Tell the dental team the exact medicine, dose, route, start date, and most recent dose if known; do not rely on the phrase “bone medicine” alone.
What medication-related jaw osteonecrosis means
MRONJ is a rare problem in which jaw bone does not heal normally and may become exposed in the mouth. The National Institute of Dental and Craniofacial Research notes that it can be associated with long-term bisphosphonate treatment and may follow a dental extraction or other bone surgery. The ADA describes a wider group of antiresorptive medicines, including denosumab. A dentist or oral surgeon evaluates the mouth and the treatment history; a patient cannot confirm MRONJ from a symptom or photograph. It is also not the same as ordinary post-extraction soreness, which is common and has many possible causes.
The risk depends on the treatment context
The risk is not identical for every patient. The indication and dose matter: cancer regimens may differ substantially from osteoporosis regimens, so statistics or advice for one group should not be applied automatically to another. Other details—such as treatment duration, the planned dental procedure, active infection, other health conditions, and medicines that may affect healing—can influence the discussion. The ADA's patient guidance describes MRONJ as uncommon at osteoporosis dosing and notes that the evidence base has limits. A published estimate is a population-level figure, not a prediction for an individual. Ask the dental and prescribing teams to explain the risks that apply to the actual treatment plan.
Extraction is not the same as a routine check-up
A routine cleaning, filling, or examination is not the same as surgery involving the jaw bone. The ADA's expert-panel guidance says routine dental treatment should not be changed solely because a person takes an antiresorptive medicine for osteoporosis. That statement is not a guarantee that every procedure is risk-free; it is a reminder not to skip ordinary oral care automatically. For an extraction, implant, periodontal surgery, or another procedure that may affect bone, the dentist can review the necessity and timing with the prescriber. Do not postpone urgent treatment for infection just because an online article raises a concern—contact the dental office and explain the medicine promptly.
Share a complete medicine and dental history
Before the appointment, gather the names and doses of prescription medicines, over-the-counter drugs, and supplements, plus the date of the last osteoporosis dose or injection. Mention why the medicine was prescribed, how long it has been used, and whether treatment is for osteoporosis or cancer-related bone disease. Include other conditions and medicines the dentist asks about, especially those that can affect healing. If you have a prescribing specialist, ask how the dentist can reach that office. The dentist also needs details about the proposed procedure, current tooth or gum symptoms, prior dental complications, and any allergies. A complete history helps the teams coordinate; it does not diagnose the jaw condition.
Routine care usually continues
Regular dental examinations and good oral hygiene remain important. NIDCR advises routine dental care and hygiene as ways to lower the chance of problems that could eventually require more invasive treatment. The ADA's osteoporosis-specific page says an oral-health program and regular dental care may be the best available prevention approach, while also acknowledging that the evidence is limited. Keep routine visits unless the dentist gives a specific reason to change them. Tell the dental team about a new bone medicine when it is prescribed, rather than waiting until an extraction is scheduled. For optional commercial reading, the existing Bone Density Solution page discusses general bone-health routines; it is not a dental or medication-safety source.
When an extraction or implant is being considered
If a tooth is badly damaged or infected, the dentist will assess whether it can be restored or whether removal is needed. Dental guidance emphasizes treating active infection and planning the least traumatic effective approach; it does not mean that a person should request a particular technique or avoid a necessary extraction. Ask what the procedure involves, what alternatives exist, how the site will be monitored, and who to call if healing does not follow expectations. A dentist may coordinate with the prescriber or refer to an oral and maxillofacial specialist when the situation warrants it. The right plan depends on examination and clinical details that cannot be evaluated online.
Why a drug holiday is not a do-it-yourself solution
Patients sometimes hear about a “drug holiday,” meaning a temporary pause before dental surgery. Professional recommendations are not fully aligned, and evidence has not established a universal pause that prevents MRONJ. The ADA says evidence is insufficient to recommend an antiresorptive holiday or a waiting period before dental treatment for osteoporosis. AAOMS likewise describes the evidence as inconclusive and reports that its working group did not reach consensus on routine holidays. This is why a patient should not stop, delay, or restart a medicine based on a general rule from a website. The prescriber and dental professional should weigh the procedure, fracture risk, infection, treatment history, and available evidence together.
Denosumab needs especially careful coordination
Denosumab deserves particular care because its timing is scheduled and stopping can have consequences for bone health. AAOMS discusses a rebound increase in bone resorption and increased risk of multiple vertebral fractures after discontinuation in osteoporosis patients. That does not mean a dental procedure can never affect a dose schedule; it means timing must be planned by the prescribing clinician and dental team, not improvised by the patient. Do not skip an injection or postpone it because an extraction is planned unless the prescriber gives a specific plan. If a dose is approaching and dental treatment is pending, contact the prescribing office early so both teams can coordinate.
A blood test cannot reliably certify dental risk
A blood test sometimes promoted online as a way to decide whether extraction is “safe” should not be treated as a clearance certificate. The ADA says there is insufficient evidence to recommend serum C-terminal telopeptide (CTX) testing to predict MRONJ risk in people taking osteoporosis medicines. AAOMS also says bone-turnover markers are not validated for clinical decision-making in this setting. A clinician may order laboratory tests for another reason, but a result cannot replace a dental examination or an individualized medication review. If someone suggests a test, ask what decision it would change and whether the dental and prescribing teams consider it useful for that person's situation.
Oral hygiene and follow-up still matter
Good brushing, interdental cleaning, and regular professional care help maintain oral health, but no self-care routine guarantees that a complication will not occur. Follow the dentist's aftercare instructions for a procedure and keep the follow-up visit if one is arranged. Do not use leftover antibiotics, mouth rinses, or supplements as a substitute for professional advice. If pain, swelling, drainage, a loose tooth, numbness, or a non-healing area develops, contact the dentist or oral surgeon and mention the osteoporosis medicine. These symptoms have multiple possible causes; they are reasons to seek an assessment, not proof of MRONJ.
Symptoms to report after dental treatment
NIDCR lists exposed jaw bone that persists, loose teeth, pain, soft-tissue swelling, drainage, or a numb or heavy feeling in the jaw among possible signs of osteonecrosis. Its information notes that exposed bone lasting more than eight weeks is one diagnostic feature considered by professionals. Do not wait eight weeks to report a concerning wound or worsening symptoms; that threshold is not a recommended waiting period. If you notice a problem after extraction or other oral surgery, call the dentist who performed the procedure and the clinician managing the bone medicine. Seek urgent care for severe or rapidly worsening symptoms, uncontrolled bleeding, fever with facial swelling, or difficulty breathing or swallowing.
Questions for the dentist and prescribing clinician
Useful questions include: Which exact medicine and dose should be listed in my dental record? Does this planned procedure involve jaw bone? Is it urgent, and what are the alternatives? Should you speak with the clinician who prescribed my treatment? Is a specialist consultation warranted? What symptoms should prompt a call, and when is follow-up planned? If a medication change is discussed, who will make that decision and when should it take effect? Ask for the plan in writing if the timing is complicated. The site's optional Chronic Kidney Disease Solution and Arthritis Strategy pages are commercial wellness resources, not clinical sources or substitutes for this discussion.
The practical takeaway: coordinate, do not panic or stop medicine
Most people taking osteoporosis-dose antiresorptive medicine can continue to receive needed dental care, but the right plan depends on the specific medicine and procedure. Tell the dentist and prescriber what you take, keep routine oral care, and coordinate before a planned bone procedure. Do not stop a bisphosphonate or delay denosumab on your own; professional guidance does not support a universal do-it-yourself drug holiday, and interruption can carry fracture-related risks. Seek an assessment for persistent exposed bone, swelling, drainage, or other concerning symptoms. This article is general education, not diagnosis or personal medical advice; it does not replace a dentist, oral surgeon, or prescribing clinician. Mr.Hotsia's editorial review is limited to source checking and clarity; it is not clinical review and does not imply medical credentials.
Sources and further reading
Medical information was checked against these public health sources on November 6, 2026.
- American Dental Association — Osteoporosis Medications and Medication-Related Osteonecrosis of the Jaw ↗
- National Institute of Dental and Craniofacial Research (NIH) — Osteonecrosis of the Jaw ↗
- American Association of Oral and Maxillofacial Surgeons — Medication-Related Osteonecrosis of the Jaw: 2022 Update ↗
This article is general health education, not a diagnosis or personal medical advice. Do not change treatment or supplements based on this article. Discuss individual results with a qualified healthcare professional.